Showing results (441-450 of 490) with videos related to
Sort By:
Pageof 49
BMJ (Clinical Research Ed.)|February 16, 2013
Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trialsPavel S Roshanov, Natasha Fernandes, Jeff M Wilczynski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancerDavid R Spigel, Howard A Burris, F Anthony Greco, et al.Cancer Nursing|January 10, 2012
Health-related quality of life of african american breast cancer survivors compared with healthy African American womenDiane M Von Ah, Kathleen M Russell, Janet Carpenter, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|December 1, 2007
Impact of folic acid food fortification on the birth prevalence of lipomyelomeningocele in CanadaPhilippe De Wals, Margot I Van Allen, R Brian Lowry, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|July 26, 2008
Spina bifida before and after folic acid fortification in CanadaPhilippe De Wals, Fassiatou Tairou, Margot I Van Allen, et al.The New England Journal of Medicine|July 13, 2007
Reduction in neural-tube defects after folic acid fortification in CanadaPhilippe De Wals, Fassiatou Tairou, Margot I Van Allen, et al.Cancer|September 21, 2019
Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trialShelley A Johns, Patrick V Stutz, Tasneem L Talib, et al.Cell Reports|November 25, 2020
Phox2a Defines a Developmental Origin of the Anterolateral System in Mice and HumansR Brian Roome, Farin B Bourojeni, Bishakha Mona, et al.Transplantation|August 2, 2014
A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomesR Brian Stevens, Kirk W Foster, Clifford D Miles, et al.Journal of Medicinal Chemistry|December 20, 1996
Bicyclic N-hydroxyurea inhibitors of 5-lipoxygenase: pharmacodynamic, pharmacokinetic, and in vitro metabolic studies characterizing N-hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)ureaJ L Adams, R S Garigipati, M Sorenson, et al.Pageof 49